Ignite Creation Date:
2024-05-06 @ 12:31 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03786107
Status:
TERMINATED
Last Update Posted:
2021-05-19
First Post:
2018-12-20
Brief Title:
HER-Seq A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
Sponsor:
Puma Biotechnology Inc
Organization:
Puma Biotechnology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2021-01-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-01-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-12-20
First Submit QC Date:
December 20 2018
Study First Post Date:
2018-12-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-17
Last Update Post Date:
2021-05-19
Last Update Post Date Type:
ACTUAL